Who Is a Candidate
GLP-1/GLP-3 therapy may be appropriate for patients with a BMI over 27 with metabolic comorbidities, those with documented insulin resistance or type 2 diabetes, and patients who have struggled to achieve meaningful results through diet and exercise alone. All candidates are evaluated with a full medical history and comprehensive labs.